Page last updated: 2024-10-23

aspirin and Carcinoma, Pancreatic Ductal

aspirin has been researched along with Carcinoma, Pancreatic Ductal in 10 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

Research Excerpts

ExcerptRelevanceReference
"Current available therapies for pancreatic ductal adenocarcinoma (PDAC) provide minimal overall survival benefits and cause severe adverse effects."5.62Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity. ( Amin, S; K Pandey, M; Karelia, DN; Kim, S; Lu, J; Plano, D; Sharma, AK, 2021)
"Current available therapies for pancreatic ductal adenocarcinoma (PDAC) provide minimal overall survival benefits and cause severe adverse effects."1.62Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity. ( Amin, S; K Pandey, M; Karelia, DN; Kim, S; Lu, J; Plano, D; Sharma, AK, 2021)
"Furthermore, development of invasive pancreatic cancer in LsL-Kras(G12D); LsL-Trp53(R172H); Pdx1-Cre transgenic mice was partially inhibited by enalapril and aspirin."1.36The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. ( Bartsch, DK; Buchholz, M; Chen, NM; Feldmann, G; Fendrich, V; Maitra, A; Neef, M; Slater, EP; Waldmann, J, 2010)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (90.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Bassani-Sternberg, M1
Digklia, A1
Huber, F1
Wagner, D1
Sempoux, C1
Stevenson, BJ1
Thierry, AC1
Michaux, J1
Pak, H1
Racle, J1
Boudousquie, C1
Balint, K1
Coukos, G1
Gfeller, D1
Martin Lluesma, S1
Harari, A1
Demartines, N1
Kandalaft, LE1
Choi, JH1
Lee, SH1
Huh, G1
Chun, JW1
You, MS1
Paik, WH1
Ryu, JK1
Kim, YT1
Karelia, DN1
Kim, S1
K Pandey, M1
Plano, D1
Amin, S1
Lu, J1
Sharma, AK1
Mensah, ET1
Smyrk, T1
Zhang, L1
Bick, B1
Wood-Wentz, CM1
Buttar, N1
Chari, ST1
Gleeson, FC1
Kendrick, M1
Levy, M1
Pearson, R1
Petersen, BT1
Vege, S1
Enders, F1
Limburg, P1
Topazian, M1
Plassmeier, L1
Knoop, R1
Waldmann, J2
Kesselring, R1
Buchholz, M2
Fichtner-Feigl, S1
Bartsch, DK2
Fendrich, V2
McAllister, F1
Leach, SD1
Zhang, Y1
Liu, L1
Fan, P1
Bauer, N1
Gladkich, J1
Ryschich, E1
Bazhin, AV1
Giese, NA1
Strobel, O1
Hackert, T1
Hinz, U1
Gross, W1
Fortunato, F1
Herr, I1
Chen, NM1
Neef, M1
Feldmann, G1
Slater, EP1
Maitra, A1
Tan, XL1
Reid Lombardo, KM1
Bamlet, WR1
Oberg, AL1
Robinson, DP1
Anderson, KE1
Petersen, GM1
Rao, CV1
Mohammed, A1
Janakiram, NB1
Li, Q1
Ritchie, RL1
Lightfoot, S1
Vibhudutta, A1
Steele, VE1

Trials

1 trial available for aspirin and Carcinoma, Pancreatic Ductal

ArticleYear
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patie
    Frontiers in immunology, 2019, Volume: 10

    Topics: Amino Acid Sequence; Antigens, Neoplasm; Antineoplastic Agents, Immunological; Aspirin; Carcinoma, P

2019

Other Studies

9 other studies available for aspirin and Carcinoma, Pancreatic Ductal

ArticleYear
The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
    Cancer medicine, 2019, Volume: 8, Issue:17

    Topics: Adult; Aged; Aspirin; Carcinoma, Pancreatic Ductal; Case-Control Studies; Female; Humans; Hydroxymet

2019
Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity.
    International journal of molecular sciences, 2021, May-07, Volume: 22, Issue:9

    Topics: Acetylcysteine; Adenocarcinoma; Apoptosis; Aspirin; Carcinoma, Pancreatic Ductal; Caspases; Cell Lin

2021
Cyclooxygenase-2 and Cytosolic Phospholipase A2 Are Overexpressed in Mucinous Pancreatic Cysts.
    Clinical and translational gastroenterology, 2019, Volume: 10, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carcinoma, Pancreatic Ductal; Cyclooxygenase 2; Cyclooxygen

2019
Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancer.
    Langenbeck's archives of surgery, 2013, Volume: 398, Issue:7

    Topics: Animals; Antimetabolites, Antineoplastic; Aspirin; Carcinoma, Pancreatic Ductal; Cyclooxygenase Inhi

2013
Targeting IL-17 for pancreatic cancer prevention.
    Oncotarget, 2014, Oct-30, Volume: 5, Issue:20

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; Carcinoma, Pancreatic Duct

2014
Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.
    Oncotarget, 2015, Apr-30, Volume: 6, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Biomarkers, Tumor; Carcinoma, Panc

2015
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
    Gut, 2010, Volume: 59, Issue:5

    Topics: Amylases; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Aspirin; Carci

2010
Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study.
    Cancer prevention research (Philadelphia, Pa.), 2011, Volume: 4, Issue:11

    Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Car

2011
Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.
    Neoplasia (New York, N.Y.), 2012, Volume: 14, Issue:9

    Topics: Animals; Anticarcinogenic Agents; Aspirin; beta Catenin; Body Weight; Carcinoma in Situ; Carcinoma,

2012